NCT07120802 Better4All Personalized Intervention Pilot Study
| NCT ID | NCT07120802 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Harokopio University |
| Condition | Obesity Prevention |
| Study Type | INTERVENTIONAL |
| Enrollment | 490 participants |
| Start Date | 2025-06-01 |
| Primary Completion | 2025-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 490 participants in total. It began in 2025-06-01 with a primary completion date of 2025-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The BETTER4U project (Preventing obesity through Biologically and bEhaviorally Tailored inTERventions for you) is funded by the European Union (EU) and involves an international consortium consisting of 28 partners across Europe, Israel, and Australia. The project started in November 2023 and will run until October 2027. The main aim of BETTER4U is to improve weight management through a tailor-made intervention, the "BETTER4ALL personalized intervention", using modern monitoring tools and artificial intelligence (AI), including machine learning (ML) practices. In the context of the BETTER4U project, the present Pilot Study aims to a) evaluate the usability, feasibility and acceptability of the BETTER4U mobile application ("BETTER4U App") and Intervention Platform that will be used to monitor and collect data from participants in the BETTER4ALL personalized intervention (randomized controlled trial; RCT) and b) collect data to evaluate and improve the BETTER4U causal AI models for the prevention of weight gain, before deploying them at large scale, as well as test and identify the optimal ways of delivering the AI-based interventions to the participants. The study will be conducted in seven sites in Cyprus, France, Greece, Poland, Portugal, Spain, and Sweden. The BETTER4All Pilot Study will be a longitudinal, correlational, observational study, including a total of n=490 participants, equally distributed among the seven sites (i.e. n=70 per site). Specifically, n=60 (± 3-5) "general population" participants (henceforth: "end-users" of the wearables and the BETTER4U App) and n=10 (± 3-5) healthcare or other types of providers (henceforth: potential "implementers" of the BETTER4U intervention) will constitute each site's sample. The study will involve the following two components: a) the administration of the wearables (smartwatches) to the "end-users" and their registration to and training on the BETTER4U App, to be used for a total duration of three weeks (21 days). During this period, their lifestyle behaviours (i.e. "BETTER4U Core Behavioural Indicators - BCBIs", such as eating occasions, physical activity, sedentary time, sleep etc.) and "living environment indicators - LEIs"; (e.g. access to parks in your area, distance from your home to your work place etc.) will be recorded daily, either in an automated way via the wearables or self-reported by the end-users through the App; and b) the registration to and training on the BETTER4U Intervention Platform of the "implementers" for a total duration of one week (7 days), during which they will be asked to test the platform's functionalities using synthetic data. The implementers will also be provided with the wearables and the App (similarly to the end-users) for one week only to allow collection of additional data that will help verify the accuracy of the algorithms in the gathered data from the wearables/monitoring tools regarding BCBIs and LEIs. Overall, the outcomes and the findings of the Pilot Study will be used to further refine, optimize, and adjust the tools for the BETTER4ALL RCT, according to the feedback received by both end-users' and implementers' perspectives.
Eligibility Criteria
Inclusion Criteria: * Age: Participants aged 18-65 years to represent the adult general population. * Body Mass Index (BMI): * Overweight or obesity group: BMI ≥ 25 kg/m². * Normal weight group: BMI 18.5-24.9 kg/m². * Technology Use: * Willingness and ability to use wearable devices and an Android mobile application for the duration of the study. * Owning a smartphone device with the Android operating system. * Eating utensil technique: dominant hand gestures that correspond to handling of food via a fork or a spoon. * Language Proficiency: Ability to read and understand the language in which the mobile app and study materials are provided. * Consent: Willing to provide informed consent to participate in the study. * Residency: Must be a resident of one of the seven participating countries. * Availability: Able to participate for the full three-week duration of the study and comply with the study protocol. Exclusion Criteria: * Health Conditions: Pregnant or breastfeeding women, as they might have different lifestyle behaviours or health needs. * Physical Limitations: Any physical or mental condition that would prevent the participant from using the wearable device or mobile application as intended. * Eating utensil technique: eating food with chopsticks on a daily or regular basis. * Technical Incompatibility: Individuals who do not own a compatible smartphone or are unable to use the provided wearable devices for technical reasons.
Contact & Investigator
Yannis Manios, Professor
PRINCIPAL INVESTIGATOR
Department of Nutrition and Dietetics, School of Health Science & Education, Harokopio University, Athens, Greece
Frequently Asked Questions
Who can join the NCT07120802 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Obesity Prevention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07120802 currently recruiting?
Yes, NCT07120802 is actively recruiting participants. Contact the research team at manios@hua.gr for enrollment information.
Where is the NCT07120802 trial being conducted?
This trial is being conducted at Nicosia, Cyprus, Villeurbanne, France, Athens, Greece, Wroclaw, Poland and 3 additional locations.
Who is sponsoring the NCT07120802 clinical trial?
NCT07120802 is sponsored by Harokopio University. The principal investigator is Yannis Manios, Professor at Department of Nutrition and Dietetics, School of Health Science & Education, Harokopio University, Athens, Greece. The trial plans to enroll 490 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.